A Case of Delayed and Persistent Carbamazepine Overdose Treated With Hemodialysis, Plasmapheresis, and Neostigmine.

TegretolTM carbamazepine carbamazepine toxicity hemodialysis plasmapheresis

Journal

Journal of pharmacy practice
ISSN: 1531-1937
Titre abrégé: J Pharm Pract
Pays: United States
ID NLM: 8900945

Informations de publication

Date de publication:
14 Aug 2024
Historique:
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 14 8 2024
Statut: aheadofprint

Résumé

Carbamazepine is utilized for various indications. Due to its pharmacokinetic profile and drug properties, toxicity can be delayed and persistent despite supportive care. We report a severe case of intentional carbamazepine toxicity in a carbamazepine naive individual mimicking brain death that was not diagnosed until three days after consumption of carbamazepine when the patient was comatose. Symptoms of overdose persisted for several days despite attempted treatment with activated charcoal and whole bowel irrigation, hemodialysis, and plasmapheresis. Symptoms only began to improve with bowel evacuation as a result of administration of neostigmine intravenously plus hemodialysis and plasmapheresis additionally. Despite previous literature that reported success with hemodialysis and/or plasmapheresis we did not find either to be overly effective in our case possibly due to lack of ability to perform multidose activated charcoal and whole bowel irrigation. To our knowledge this is one of the few cases of carbamazepine overdose utilizing both hemodialysis and plasmapheresis but without activated charcoal and the only case report in which neostigmine was administered as an attempt to remove drug via the gastrointestinal tract with success.

Identifiants

pubmed: 39140484
doi: 10.1177/08971900241273234
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8971900241273234

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Kayla M Cameron-Coffill (KM)

Clinical Pharmacist Intensive Care, Horizon Health Network, Pharmacy Department, Saint John Regional Hospital, Saint John, NB, Canada.

Hari K Ondiveeran (HK)

Department of Surgery, Horizon Health Network, Saint John Regional Hospital, Saint John, NB, Canada.

Liam D Walsh (LD)

Clinical Emergency Medicine Pharmacist, Horizon Health Network, Pharmacy Department, Saint John Regional Hospital, Saint John, NB, Canada.

Classifications MeSH